DrugCite
Search

FTY

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Fty Adverse Events Reported to the FDA Over Time

How are Fty adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Fty, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Fty is flagged as the suspect drug causing the adverse event.

Most Common Fty Adverse Events Reported to the FDA

What are the most common Fty adverse events reported to the FDA?

Basal Cell Carcinoma
79 (1.87%)
Multiple Sclerosis Relapse
68 (1.61%)
Central Nervous System Lesion
58 (1.38%)
Asthenia
53 (1.26%)
Nausea
51 (1.21%)
Headache
45 (1.07%)
Constipation
44 (1.04%)
Breast Cancer
43 (1.02%)
Skin Lesion
43 (1.02%)
Gait Disturbance
42 (1%)
Muscular Weakness
39 (.93%)
Show More Show More
Abasia
38 (.9%)
Status Epilepticus
38 (.9%)
Convulsion
36 (.85%)
Cyanosis
36 (.85%)
Pyrexia
36 (.85%)
Brain Oedema
35 (.83%)
Decreased Appetite
35 (.83%)
Back Pain
34 (.81%)
Loss Of Consciousness
34 (.81%)
Muscle Spasticity
34 (.81%)
Dysarthria
33 (.78%)
Aphasia
32 (.76%)
Ataxia
30 (.71%)
Dysmetropsia
30 (.71%)
Hemianopia Homonymous
30 (.71%)
Irritability
30 (.71%)
Metamorphopsia
30 (.71%)
Tonic Clonic Movements
30 (.71%)
Unresponsive To Stimuli
30 (.71%)
Gamma-glutamyltransferase Increased
29 (.69%)
Lymphadenopathy
29 (.69%)
Peripheral Coldness
28 (.66%)
Visual Impairment
27 (.64%)
Cerebellar Syndrome
26 (.62%)
Hypertension
25 (.59%)
Muscle Spasms
25 (.59%)
Paraesthesia
25 (.59%)
Skin Neoplasm Excision
25 (.59%)
Bone Neoplasm Malignant
24 (.57%)
Bone Pain
24 (.57%)
Dizziness
24 (.57%)
Metastases To Lymph Nodes
24 (.57%)
Neoplasm Malignant
24 (.57%)
Pyramidal Tract Syndrome
24 (.57%)
Vasospasm
24 (.57%)
Vomiting
24 (.57%)
Chest Pain
23 (.55%)
Disorientation
23 (.55%)
Tongue Biting
23 (.55%)
Vision Blurred
23 (.55%)
Concomitant Disease Progression
22 (.52%)
Disturbance In Attention
22 (.52%)
Lymphoma
22 (.52%)
Paresis
22 (.52%)
Colour Blindness
20 (.47%)
Depressed Mood
20 (.47%)
Drug Exposure During Pregnancy
20 (.47%)
Dysphonia
20 (.47%)
Joint Injury
20 (.47%)
Metastatic Neoplasm
20 (.47%)
Urinary Incontinence
20 (.47%)
Drug Ineffective
19 (.45%)
Memory Impairment
19 (.45%)
Rash
19 (.45%)
Cerebral Atrophy
18 (.43%)
Disinhibition
18 (.43%)
Malignant Urinary Tract Neoplasm
18 (.43%)
Breast Dysplasia
17 (.4%)
Fall
16 (.38%)
Myocardial Infarction
16 (.38%)
Papilloma
16 (.38%)
Herpes Zoster
15 (.36%)
Lymphopenia
15 (.36%)
Blood Creatinine Increased
14 (.33%)
Diarrhoea
14 (.33%)
Hypoaesthesia
14 (.33%)
Nystagmus
14 (.33%)
Optic Neuritis
14 (.33%)
Pain In Extremity
14 (.33%)
Vertigo
14 (.33%)
Brain Mass
13 (.31%)
Breast Mass
13 (.31%)
Cystitis
13 (.31%)
Grand Mal Convulsion
13 (.31%)
Hemiparesis
13 (.31%)
Malaise
13 (.31%)
Confusional State
12 (.28%)
Dyspnoea
12 (.28%)
Epilepsy
12 (.28%)
Facial Paresis
12 (.28%)
Fatigue
12 (.28%)
Lymphomatoid Papulosis
12 (.28%)
Melanocytic Naevus
12 (.28%)
Polyneuropathy
12 (.28%)
Surgery
12 (.28%)
Viith Nerve Paralysis
12 (.28%)
Blister
11 (.26%)
Bradycardia
11 (.26%)
Escherichia Infection
11 (.26%)
Influenza Like Illness
11 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Fty, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Fty is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Fty

What are the most common Fty adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Fty, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Fty is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Fty According to Those Reporting Adverse Events

Why are people taking Fty, according to those reporting adverse events to the FDA?

Multiple Sclerosis
444
Relapsing-remitting Multiple Sclero...
24
Renal Transplant
8
Multiple Sclerosis Relapse
5
Primary Progressive Multiple Sclero...
4
Product Used For Unknown Indication
2
Show More Show More

Fty Case Reports

What Fty safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Fty. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Fty.